Page last updated: 2024-12-11

uroguanylin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

uroguanylin: amino acid sequence given in first source; stimulates intestinal guanylate cyclase; GenBank Z83746 (pig) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5488765
SCHEMBL ID6442033
MeSH IDM0224171

Synonyms (8)

Synonym
uroguanylin
guanylin (rat reduced), 1-l-glutamine-2-l-glutamic acid-3-l-aspartic acid-6-l-leucine-8-l-isoleucine-9-l-asparagine-10-l-valine-
152175-68-3
ewy1xp1hmz ,
unii-ewy1xp1hmz
SCHEMBL6442033
DTXSID10164965
Q7900863

Research Excerpts

Overview

Uroguanylin is a 16 amino acid peptide that constitutes a key component of the gut- brain axis with special relevance in body weight regulation. It acts on membrane-bound guanylate cyclase receptors of intestinal and renal cells increasing cGMP production and regulating electrolyte and water epithelial transport.

ExcerptReferenceRelevance
"Uroguanylin (UGN) is a potential target in the fight against obesity. "( Uroguanylin: a new actor in the energy balance movie.
Barja-Fernandez, S; Casanueva, FF; Castelao, C; Folgueira, C; Gonzalez-Saenz, P; Nogueiras, R; Pena-Leon, V; Ruiz-Piñon, M; Seoane, LM, 2018
)
3.37
"Uroguanylin is a 16 amino acid peptide that constitutes a key component of the gut- brain axis with special relevance in body weight regulation. "( Circulating Pro-Uroguanylin Levels In Children And Their Relation To Obesity, Sex And Puberty.
Barja-Fernández, S; Casanueva, FF; Castelao, C; Dieguez, C; Folgueira, C; Gonzalez-Saenz, P; Leis, R; Nogueiras, R; Pena-Leon, V; Ruiz-Piñon, M; Seoane, LM; Vázquez-Cobela, R, 2018
)
2.27
"Uroguanylin (UGN) is an endogenous peptide that acts on membrane-bound guanylate cyclase receptors of intestinal and renal cells increasing cGMP production and regulating electrolyte and water epithelial transport. "( Uroguanylin induces electroencephalographic spikes in rats.
Fonteles, MC; Nascimento, NR; Teixeira, MD; Vale, OC, 2013
)
3.28
"Uroguanylin is a gastrointestinal hormone primarily involved in fluid and electrolyte handling. "( Effect of guanylate cyclase-C activity on energy and glucose homeostasis.
Begg, DP; Chambers, AP; Cohen, MB; Haller, A; Kohli, R; Mul, JD; Seeley, RJ; Steinbrecher, KA; Woods, SC, 2014
)
1.85
"Uroguanylin (UGN) is a 16 amino acid peptide produced mainly by intestinal epithelial cells. "( Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner.
Barja-Fernandez, S; Casanueva, FF; Dieguez, C; Folgueira, C; Leis, R; Nogueiras, R; Sanchez-Rebordelo, E; Seoane, LM; Tovar, S, 2016
)
3.32
"Uroguanylin (UGN) is a peptide hormone that binds to and activates the intestinal epithelial cell (IEC) transmembrane receptor guanylate cyclase C (GC-C), which in turn increases intracellular cGMP. "( Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis.
Cohen, MB; Garin-Laflam, MP; Mao, J; Rudolph, JA; Steinbrecher, KA, 2009
)
1.8
"Uroguanylin is an endogenous peptide agonist that binds to the guanylate cyclase C receptor (GC-C). "( In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone.
Daibes-Figueroa, S; Forte, LR; Giblin, MF; Hoffman, TJ; Liu, D; Overbey, D; Volkert, WA; Watkinson, LD, 2009
)
2.02
"Prouroguanylin is a gastrointestinal paracrine signal and prohormone that is secreted after nutrient ingestion. "( Uroguanylin: how the gut got another satiety hormone.
Seeley, RJ; Tschöp, MH, 2011
)
2.43
"The uroguanylin system is a newly discovered endocrine/paracrine system that may have a role in the regulation of salt balance, appetite and gut health. "( The uroguanylin system and human disease.
Jones, DJ; Narayan, H; Ng, LL; Rahbi, H, 2012
)
1.5
"Uroguanylin is an endogenous peptide that stimulates cyclic guanosine monophosphate (cGMP) production via the activation of guanylate cyclase C (GC-C) in the intestine and kidney. "( Effects of uroguanylin, an intestinal natriuretic peptide, on tubuloglomerular feedback.
Haneda, M; Kawabata, M; Takabatake, T; Wang, T, 2003
)
2.15
"Uroguanylin is a peptide hormone that regulates sodium excretion by the kidney when excess NaCl is consumed. "( A novel role for uroguanylin in the regulation of sodium balance.
Forte, LR, 2003
)
2.1
"Uroguanylin is a small peptide isolated from opossum urine that activates membrane guanylate cyclases. "( Uroguanylin: cloning of preprouroguanylin cDNA, mRNA expression in the intestine and heart and isolation of uroguanylin and prouroguanylin from plasma.
Currie, MG; Eber, SL; Fan, X; Forte, LR; Freeman, RH; Hamra, FK; Krause, WJ; Lim, RW; Pace, VM, 1996
)
3.18
"Uroguanylin is an endogenous ligand of the intestinal receptor guanylate cyclase-C (GC-C). "( The uroguanylin gene (Guca1b) is linked to guanylin (Guca2) on mouse chromosome 4.
Cohen, MB; Copeland, NG; Gilbert, DJ; Jenkins, NA; Steinbrecher, KA; Whitaker, TL, 1997
)
2.3
"Uroguanylin is an intestinal peptide hormone that may regulate epithelial ion transport by activating a receptor guanylyl cyclase on the luminal surface of the intestine. "( Regulation of intestinal Cl- and HCO3-secretion by uroguanylin.
Clarke, LL; Forte, LR; Joo, NS; Kim, HD; London, RM, 1998
)
1.99
"Uroguanylin is an endogenous peptide ligand for guanylyl cyclase-C, an apical membrane receptor predominantly located in the gastrointestinal epithelium. "( Enterochromaffin-like cells, a cellular source of uroguanylin in rat stomach.
Chiba, T; Date, Y; Kangawa, K; Kinoshita, Y; Matsukura, S; Nakazato, M; Ueta, Y; Yamaguchi, H; Yamashita, H, 1999
)
2
"Uroguanylin is a small-molecular-weight peptide that activates membrane-bound receptor-guanylate cyclases in the intestine, kidney, and other epithelia. "( Increased urinary excretion of uroguanylin in patients with congestive heart failure.
Carrithers, SL; Eber, SL; Forte, LR; Greenberg, RN, 2000
)
2.04
"Uroguanylin is a novel natriuretic and diuretic peptide originally isolated from urine."( Uroguanylin level in umbilical cord blood.
Date, Y; Hiraoka, M; Kotsuji, F; Mayumi, M; Miura, M; Nakazato, M; Nishida, K; Sekine, K; Tsukahara, H; Tsunezawa, W; Uchiyama, M, 2001
)
3.2

Effects

Uroguanylin has a widespread tissue distribution and is located in cells that function in an endocrine, paracrine, and/or luminocrine (luminal secretion) fashion. It has been shown to participate in the regulation of salt and water homeostasis in mammals via cGMP-mediated processes.

ExcerptReferenceRelevance
"Uroguanylin has a widespread tissue distribution and is located in cells that function in an endocrine, paracrine, and/or luminocrine (luminal secretion) fashion."( Tissue distribution, cellular source, and structural analysis of rat immunoreactive uroguanylin.
Chino, N; Date, Y; Goy, MF; Kangawa, K; Matsukura, S; Miyazato, M; Nakazato, M; Yamaguchi, H, 1998
)
1.25
"Uroguanylin (UGN) has been recently proposed to be a part of this gut-brain axis regulating food intake, body weight and energy expenditure."( Uroguanylin Improves Leptin Responsiveness in Diet-Induced Obese Mice.
Beiroa, D; Casanueva, FF; Castelao, C; Diéguez, C; Folgueira, C; García-Palacios, M; González-Rellán, MJ; López, M; Milbank, E; Nogueiras, R; Porteiro, B; Seoane, LM, 2019
)
2.68
"Uroguanylin (UGN) has been proposed as a key regulator of salt and water intestinal transport. "( Uroguanylin regulates net fluid secretion via the NHE2 isoform of the Na/H+ exchanger in an intestinal cellular model.
Capurro, C; Curto, MA; Dorr, RA; Ozu, M; Politi, MT; Toriano, R, 2011
)
3.25
"Uroguanylin has a widespread tissue distribution and is located in cells that function in an endocrine, paracrine, and/or luminocrine (luminal secretion) fashion."( Tissue distribution, cellular source, and structural analysis of rat immunoreactive uroguanylin.
Chino, N; Date, Y; Goy, MF; Kangawa, K; Matsukura, S; Miyazato, M; Nakazato, M; Yamaguchi, H, 1998
)
1.25
"Uroguanylin has been shown to participate in the regulation of salt and water homeostasis in mammals via cGMP-mediated processes, bearing a distinct similarity to the action of the atriopeptins, which play a defined role in natriuresis and act as prognostic indicators of severe congestive heart failure (CHF)."( Increased urinary excretion of uroguanylin in patients with congestive heart failure.
Carrithers, SL; Eber, SL; Forte, LR; Greenberg, RN, 2000
)
1.31

Actions

Uroguanylin did not increase urinary excretion of sodium and water in normal rats, but significantly increased urinary sodium excretion during the sodium retention phase in nephrotic rats. The hormone plays an important role in sodium transport in the gastrointestinal tract and functions as a natriuretic hormone during oral salt load.

ExcerptReferenceRelevance
"Uroguanylin did not increase urinary excretion of sodium and water in normal rats, but significantly increased urinary sodium excretion during the sodium retention phase in nephrotic rats (untreated vs uroguanylin-treated nephrotic rats in mmol/mmol creatinine; 2.92 +/- 0.65 vs 8.93 +/- 2.53 on day 6, P < 0.05; 3.55 +/- 0.47 vs 10.37 +/- 1.73 on day 7, P < 0.01; 14.88 +/- 2.32 vs 24.47 +/- 2.86 on day 8, P < 0.05). "( Effects of uroguanylin on natriuresis in experimental nephrotic rats.
Baba, A; Fujimoto, S; Kikuchi, M; Kita, T; Kitamura, K, 2009
)
2.19
"Uroguanylin plays an important role in sodium transport in the gastrointestinal tract and functions as an intestinal natriuretic hormone during oral salt load."( Changes in urinary levels and renal expression of uroguanylin on low or high salt diets in rats.
Eto, T; Fujimoto, S; Fukae, H; Kinoshita, H; Kita, T; Nakazato, M, 2002
)
1.29

Treatment

ExcerptReferenceRelevance
"pretreatment of uroguanylin significantly inhibited leukotriene C4-induced pulmonary changes in a dose-dependent manner, suggesting its effectiveness against an asthmatic condition."( Both inhalant and intravenous uroguanylin inhibit leukotriene C4-induced airway changes.
Ohbayashi, H; Yamaki, KI, 2000
)
0.93

Dosage Studied

ExcerptRelevanceReference
" The uroguanylin B dose-response curve is sigmoidal with a threshold dose of approximately 10 nmol/kg of body weight, whereas uroguanylin A has a comparable threshold but a bell-shaped dose-response curve."( The natriuretic peptide uroguanylin elicits physiologic actions through 2 distinct topoisomers.
Arendshorst, WJ; Currie, MG; Goy, MF; Kessler, MM; Moss, NG; Riguera, DA; Solinga, RM; Zimmer, DP, 2009
)
1.17
" Unexpectedly, comparisons of natriuretic dose-response curves for each peptide showed proUgn to be about five times more potent than Ugn, despite the relatively modest amount of Ugn generated from infused proUgn."( Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat.
Cazzolla, C; Fellner, RC; Goy, MF; Moss, NG; Riguera, DA, 2010
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (201)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's50 (24.88)18.2507
2000's81 (40.30)29.6817
2010's64 (31.84)24.3611
2020's6 (2.99)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.23 (24.57)
Research Supply Index5.33 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (1.48%)5.53%
Reviews32 (15.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other168 (82.76%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]